Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 6/20 | 0.45 |
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7754870 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL18805935 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL3406853 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL23665084 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL19770394 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL23665088 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL1527010 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL7753936 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL22779020 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL17679207 | 1.00 | FUCA1 (0.45) | FUCA1CA2CA9CA12GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118806883-A | Specific sugar fragment for research and development of vibrio cholerae vaccine | 江南大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-118791538-A | Chemical synthesis method and application of vibrio cholerae O100 serotype O antigen oligosaccharide | 江南大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-118027116-B | Pseudomonas aeruginosa O11 serotype O-antigen trisaccharide and synthesis method thereof | 山东大学 | 2024-08-23 | — | — | CN | disclosed |
| CN-118027116-B | Pseudomonas aeruginosa O11 serotype O-antigen trisaccharide and synthesis method thereof | 山东大学 | 2024-08-23 | — | — | CN | disclosed |
| CN-118027116-A | Pseudomonas aeruginosa O11 serotype O-antigen trisaccharide and synthesis method thereof | 山东大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-118027116-A | Pseudomonas aeruginosa O11 serotype O-antigen trisaccharide and synthesis method thereof | 山东大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-117957316-A | Fucosyltransferase for converting lactose-N-disaccharide | 因比奥斯公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117222736-A | Cellular production of biological products | 因比奥斯公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117157394-A | Fermentation production | 因比奥斯公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-117157396-A | Cell production of sialylated di-and/or oligosaccharides | 因比奥斯公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116096912-A | Production of a mixture of neutral nonfucosylated oligosaccharides by cells | 因比奥斯公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-116096911-A | Production of oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-05-09 | — | — | CN | disclosed |
| WO-1993012137-A1 | PHARMACEUTICAL COMPOSITIONS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-06-24 | — | — | WO | disclosed |